Keisuke Enomoto

Dr. Keisuke Enomoto


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2014 in Surgery
Verified
Journal Article
Closed access
KEKeisuke Enomoto
Keisuke Enomoto
SUShinya Uchino
Shinya Uchino
SWShin Watanabe
Shin Watanabe
YEYukie Enomoto
Yukie Enomoto
SNShiro Noguchi
Shiro Noguchi

30 June 2020 in Endocrinology and Metabolism
Verified
Journal Article
Open access
PDF file
KEKeisuke Enomoto
Keisuke Enomoto
MHMuneki Hotomi
Muneki Hotomi
Thyroid cancer cells have a high amino acid demand for proliferation, invasion, and metastasis. Amino acids are taken up by thyroid cancer cells, both thyroid follicular cell and thyroid parafollicular cells (commonly called "C-cells"), via amino acid transporters. Amino acid transporters up-regulate in many cancers, and their expression level associate with clinical aggressiveness and prognosis. This is the review to discuss the therapeutic potential of amino acid transporters and as molecular targets in thyroid cancer.

3 November 2021 in Frontiers in Immunology
Verified
Journal Article
Open access
MKMasamitsu Kono
Masamitsu Kono
DNDenisa Nanushaj
Denisa Nanushaj
HSHideki Sakatani
Hideki Sakatani
DMDaichi Murakami
Daichi Murakami
MHMasayoshi Hijiya
Masayoshi Hijiya
MHMuneki Hotomi
Muneki Hotomi
Transient receptor potential (TRP) channels, neuronal stimulations widely known to be associated with thermal responses, pain induction, and osmoregulation, have been shown in recent studies to have underlying mechanisms associated with inflammatory responses. The role of TRP channels on inflammatory milieu during bacterial infections has been widely demonstrated. It may vary among types of channels/pathogens, however, and it is not known how TRP channels function during pneumococcal infections. Streptococcus pneumoniae can cause severe infections such as pneumonia, bacteremia, and meningitis, with systemic inflammatory responses. This study examines the role of TRP channels (TRPV1 and TRPV4) for pneumococcal nasal colonization and subsequent development of invasive pneumococcal disease in a mouse model. Both TRPV1 and TRPV4 channels were shown to be related to regulation of the development of pneumococcal diseases. In particular, the influx of neutrophils (polymorphonuclear cells) in the nasal cavity and the bactericidal activity were significantly suppressed among TRPV4 knockout mice. This may lead to severe pneumococcal pneumonia, resulting in dissemination of the bacteria to various organs and causing high mortality during influenza virus coinfection. Regulating host immune responses by TRP channels could be a novel strategy against pathogenic microorganisms causing strong local/systemic inflammation.

18 February 2021 in Cancers
Verified
Journal Article
Open access
PDF file
KEKeisuke Enomoto
Keisuke Enomoto
SHShun Hirayama
Shun Hirayama
NKNaoko Kumashiro
Naoko Kumashiro
XJXuefeng Jing
Xuefeng Jing
TKTakahito Kimura
Takahito Kimura
MHMuneki Hotomi
Muneki Hotomi
E7080, known as lenvatinib, is an oral multitargeted tyrosine kinase inhibitor that has been shown to improve the survival rate of patients with radioiodine-refractory thyroid cancer. However, a majority of patients do not continue lenvatinib intake due to disease progression or significant toxicity. To improve treatment success rates, we propose the combination of lenvatinib with mitogen-activated protein kinase (MEK) inhibitors. To test this hypothesis, we tested the effects of lenvatinib with the MEK inhibitor U0126 in vitro using two human anaplastic thyroid cancer (ATC) cell lines, 8505C and TCO1, and with another MEK inhibitor, selumetinib (AZD6244), in an ATC mouse model. We found that the combination of lenvatinib with MEK inhibitors enhanced the antitumor effects of monotherapy with either agent in vitro and in vivo, and these effects may be through the AKT (Protein Kinase B) and extracellular signal-regulated kinase (ERK) signaling pathways. Furthermore, the combination does not have significant adverse effects in the ATC mouse models in terms of body weight, blood biochemical parameters, and histopathology. In conclusion, the combination of lenvatinib with an MEK inhibitor is a potentially viable therapeutic approach for ATC treatment.

18 March 2022 in Auris Nasus Larynx
Verified
Journal Article
Closed access
KEKeisuke Enomoto
Keisuke Enomoto
HIHidenori Inohara
Hidenori Inohara

2 August 2021 in Cancers
Verified
Journal Article
Open access
PDF file
Mehmet GunduzMehmet Gunduz
Mehmet Gunduz
EGEsra Gunduz
Esra Gunduz
STShunji Tamagawa
Shunji Tamagawa
KEKeisuke Enomoto
Keisuke Enomoto
MHMuneki Hotomi
Muneki Hotomi
Oropharyngeal cancer (OPC), which is a common type of head and neck squamous cell carcinoma (HNSCC), is associated with tobacco and alcohol use, and human papillomavirus (HPV) infection. Underlying mechanisms and as a result prognosis of the HPV-positive and HPV-negative OPC patients are different. Like stem cells, the ability of self-renewal and differentiate, cancer stem cells (CSCs) have roles in tumor invasion, metastasis, drug resistance, and recurrence after therapy. Research revealed their roles to some extent in all of these processes but there are still many unresolved points to connect to CSC-targeted therapy. In this review, we will focus on what we currently know about CSCs of OPC and limitations of our current knowledge. We will present perspectives that will broaden our understanding and recent literature which may connect to therapy.